z-logo
open-access-imgOpen Access
Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms
Author(s) -
M Hashemi,
John Rovig,
Brett Holden,
Maddison Taylor,
Scott Weber,
John T. Wilson,
Brian Hilton,
Aaron Zaugg,
Samuel W Ellis,
Connor D Yost,
Patrick M. Finnegan,
Charles K Kistler,
Elizabeth L. Berkow,
Shenglou Deng,
Shawn R. Lockhart,
Marnie L. Peterson,
Paul B. Savage
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky085
Subject(s) - candida auris , microbiology and biotechnology , biofilm , drug resistance , drug , medicine , biology , antifungal , bacteria , pharmacology , genetics
Candida auris has emerged as a serious threat to human health. Of particular concern are the resistance profiles of many clinical isolates, with some being resistant to multiple classes of antifungals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom